VIEKIRA PAK Trademark

Trademark Overview

On Thursday, October 16, 2014, a trademark application was filed for VIEKIRA PAK with the United States Patent and Trademark Office. The USPTO has given the VIEKIRA PAK trademark a serial number of 86425792. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 28, 2021. This trademark is owned by AbbVie Inc.. The VIEKIRA PAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Hepatitis C
viekira pak

General Information

Serial Number86425792
Word MarkVIEKIRA PAK
Filing DateThursday, October 16, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 28, 2021
Registration Number4788976
Registration DateTuesday, August 11, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Hepatitis C
Pseudo MarkVIEKIRA PACK
Translation of Words in MarkThe wording "VIEKIRA" has no meaning in a foreign language.
NOT AVAILABLE"PACK"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 23, 2014
Primary Code005
First Use Anywhere DateWednesday, December 31, 2014
First Use In Commerce DateWednesday, December 31, 2014

Trademark Owner History

Party NameAbbVie Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Wednesday, February 4, 2015ASSIGNED TO EXAMINER
Monday, October 20, 2014NEW APPLICATION ENTERED
Thursday, October 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 24, 2014NOTICE OF PSEUDO MARK E-MAILED
Thursday, February 12, 2015USE AMENDMENT ACCEPTED
Thursday, February 5, 2015NON-FINAL ACTION WRITTEN
Thursday, February 5, 2015NON-FINAL ACTION E-MAILED
Thursday, February 5, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 11, 2015TEAS AMENDMENT OF USE RECEIVED
Thursday, February 12, 2015USE AMENDMENT FILED
Thursday, February 12, 2015AMENDMENT TO USE PROCESSING COMPLETE
Thursday, February 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 6, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 26, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 11, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 21, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, February 12, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 13, 2015NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 3, 2015ASSIGNED TO LIE
Tuesday, March 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 17, 2015WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, October 28, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 28, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, August 11, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, October 28, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

viekira hepatitis treatment preparations pharmaceutical